Different isoforms of nitric oxide synthase are involved in angiotensin-(1-7)-mediated plasticity changes in the amygdala in a gender-dependent manner

Neuroendocrinology

Volumn 94, Issue 3, 2011, Pages 191-199

  Staschewski, Jörg ^a   Kulisch, Christoph ^a   Albrecht, Doris ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Amygdala; Angiotensin (1 7); Gender; Knockout mice; Long term potentiation; Neuronal and endothelial nitric oxide synthase; Nitric oxide

Indexed keywords

ANGIOTENSIN[1-7]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NERVE POTENTIAL; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

AMYGDALA; ANGIOTENSIN I; ANIMALS; ENZYME INHIBITORS; FEMALE; ISOENZYMES; LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONAL PLASTICITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; SEX CHARACTERISTICS;

EID: 81355138885     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000328128     Document Type: Article

References (50)

1. Bao AM, Swaab DF: Sex differences in the brain, behavior, and neuropsychiatric disorders. Neuroscientist 2010; 16: 550-565.
2. Hines M: Sex-related variation in human behavior and the brain. Trends Cogn Sci 2010; 14: 448-456.
3. Zald DH: The human amygdala and the emotional evaluation of sensory stimuli. Brain Res Brain Res Rev 2003; 41: 88-123. (Pubitemid 36044596)
4. Hinojosa-Laborde C, Chapa I, Lange D, Haywood JR: Gender differences in sympathetic nervous system regulation. Clin Exp Pharmacol Physiol 1999; 26: 122-126.
5. Oparil S, Miller AP: Gender and blood pressure. J Clin Hypertens (Greenwich) 2005; 7: 300-309.
6. Johns EJ: Genes, gender and blood pressure regulation. J Hypertens 2003; 21: 1447-1448. (Pubitemid 36994118)
7. Kang AK, Miller JA: Effects of gender on the renin-angiotensin system, blood pressure, and renal function. Curr Hypertens Rep 2002; 4: 143-151.
8. Pretorius M, Luther JM, Murphey LJ, Vaughan DE, Brown NJ: Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men. Arterioscler Thromb Vasc Biol 2005; 25: 2435-2440. (Pubitemid 41552667)
9. Reyes-Engel A, Morcillo L, Aranda FJ, Ruiz M, Gaitan MJ, Mayor-Olea A, Aranda P, Ferrario CM: Influence of gender and genetic variability on plasma angiotensin peptides. J Renin Angiotensin Aldosterone Syst 2006; 7: 92-97. (Pubitemid 44383503)
10. Wright JW, Yamamoto BJ, Harding JW: Angiotensin receptor subtype-mediated physiologies and behaviors: new discoveries and clinical targets. Prog Neurobiol 2008; 84: 157-181.
11. Von Bohlen und Halbach O, Albrecht D: The CNS renin-angiotensin system. Cell Tissue Res 2006; 326: 599-616. (Pubitemid 44435828)
12. Albrecht D: Physiological and pathophysiological functions of different angiotensins. Br J Pharmacol 2010; 159: 1392-1401.
13. Hellner K, Walther T, Schubert M, Albrecht D: Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 2005; 29: 427-435. (Pubitemid 40799215)
14. Albrecht D: Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO. Learn Mem 2007; 14: 177-184. (Pubitemid 46495195)
15. Von Bohlen und Halbach O, Albrecht D: Angiotensin II inhibits long-term potentiation within the lateral nucleus of the amygdala through AT1 receptors. Peptides 1998; 19: 1031-1036. (Pubitemid 28383799)
16. Santos RA, Simoes E, Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T: Angiotensin-( 1-7) is an endogenous ligand for the G-protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003; 100: 8258-8263. (Pubitemid 36842532)
17. Pogun S: Sex differences in brain and behavior: emphasis on nicotine, nitric oxide and place learning. Int J Psychophysiol 2001; 42: 195-208. (Pubitemid 32928384)
18. Barjavel MJ, Bhargava HN: Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: kinetic analysis. Pharmacology 1995; 50: 168-174.
19. Endoh M, Maiese K, Wagner JA: Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons. Neuroscience 1994; 63: 679-689. (Pubitemid 24360222)
20. Echeverry MB, Guimaraes FS, Del Bel EA: Acute and delayed restraint stress-induced changes in nitric oxide producing neurons in limbic regions. Neuroscience 2004; 125: 981-993. (Pubitemid 38553905)
21. Schafe GE, Bauer EP, Rosis S, Farb CR, Rodrigues SM, LeDoux JE: Memory consolidation of pavlovian fear conditioning requires nitric oxide signaling in the lateral amygdala. Eur J Neurosci 2005; 22: 201-211. (Pubitemid 41059986)
22. Sato T, Suzuki E, Yokoyama M, Watanabe S, Miyaoka H: Auditory fear conditioning and conditioned stress raise NO 3 level in the amygdala. Neuropsychobiology 2006; 53: 142-147. (Pubitemid 43854173)
23. Kelley JB, Balda MA, Anderson KL, Itzhak Y: Impairments in fear conditioning in mice lacking the nNOS gene. Learn Mem 2009; 16: 371-378.
24. Brosnihan KB, Li P, Ferrario CM: Angiotensin-( 1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27: 523-528. (Pubitemid 26086221)
25. Heitsch H, Brovkovych S, Malinski T, Wiemer G: Angiotensin-(1-7)- stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001; 37: 72-76. (Pubitemid 32064242)
26. Fraga-Silva RA, Pinheiro SV, Goncalves AC, Alenina N, Bader M, Santos RA: The antithrombotic effect of angiotensin-(1-7) involves Mas-mediated NO release from platelets. Mol Med 2008; 14: 28-35. (Pubitemid 351356883)
27. Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, Kandel ER: Longterm potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 1996; 87: 1015-1023. (Pubitemid 26427985)
28. Blackshaw S, Eliasson MJ, Sawa A, Watkins CC, Krug D, Gupta A, Arai T, Ferrante RJ, Snyder SH: Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity. Neuroscience 2003; 119: 979-990. (Pubitemid 36776448)
29. Doyere V, Schafe GE, Sigurdsson T, LeDoux JE: Long-term potentiation in freely moving rats reveals asymmetries in thalamic and cortical inputs to the lateral amygdala. Eur J Neurosci 2003; 17: 2703-2715. (Pubitemid 36819295)
30. O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, Fishman MC: Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 1994; 265: 542-546. (Pubitemid 24265004)
31. Doreulee N, Sergeeva OA, Yanovsky Y, Chepkova AN, Selbach O, Godecke A, Schrader J, Haas HL: Cortico-striatal synaptic plasticity in endothelial nitric oxide synthase-deficient mice. Brain Res 2003; 964: 159-163. (Pubitemid 36165081)
32. Haul S, Godecke A, Schrader J, Haas HL, Luhmann HJ: Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. J Neurophysiol 1999; 81: 494-497. (Pubitemid 29264496)
33. Williams JH, Li YG, Nayak A, Errington ML, Murphy KP, Bliss TV: The suppression of long-term potentiation in rat hippocampus by inhibitors of nitric oxide synthase is temperature and age dependent. Neuron 1993; 11: 877-884. (Pubitemid 23347472)
34. Ota KT, Pierre VJ, Ploski JE, Queen K, Schafe GE: The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase. Learn Mem 2008; 15: 792-805.
35. Watanabe Y, Saito H, Abe K: Nitric oxide is involved in long-term potentiation in the medial but not lateral amygdala neuron synapses in vitro. Brain Res 1995; 688: 233-236.
36. Von Bohlen und Halbach O, Albrecht D: Reciprocal connections of the hippocampal area CA1, the lateral nucleus of the amygdala and cortical areas in a combined horizontal slice preparation. Neurosci Res 2002; 44: 91-100. (Pubitemid 36158707)
37. De Olmos JE, Alheid GF, Beltramino CA: Amygdala; in Paxinos G (ed): The Rat Nervous System. Sydney, Academic Press, 1985, vol 1, pp 223-334.
38. Hopper RA, Garthwaite J: Tonic and phasic nitric oxide signals in hippocampal longterm potentiation. J Neurosci 2006; 26: 11513-11521. (Pubitemid 44772122)
39. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH: Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 1995; 378: 383-386.
40. Sakata A, Mogi M, Iwanami J, Tsukuda K, Min LJ, Fujita T, Iwai M, Ito M, Horiuchi M: Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function. Brain Res 2009; 1300: 14-23.
41. Carey RM, Jin XH, Wang ZQ, Siragy HM: Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol Scand 2000; 168: 65-71. (Pubitemid 30128669)
42. Scordalakes EM, Shetty SJ, Rissman EF: Roles of estrogen receptor and androgen receptor in the regulation of neuronal nitric oxide synthase. J Comp Neurol 2002; 453: 336-344. (Pubitemid 35231186)
43. Schubert M, Drephal C, Albrecht D: Genderdependent ATPA-induced changes in longterm potentiation in the rat lateral amygdala. FASEB J 2008; 22: 1268-1274. (Pubitemid 351522743)
44. Berman JR, McCarthy MM, Kyprianou N: Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology 1998; 51: 650-656. (Pubitemid 28186224)
45. Musicki B, Liu T, Lagoda GA, Bivalacqua TJ, Strong TD, Burnett AL: Endothelial nitric oxide synthase regulation in female genital tract structures. J Sex Med 2009; 6(suppl 3):247-253.
46. Zhang Y, Lu J, Shi J, Lin X, Dong J, Zhang S, Liu Y, Tong Q: Central administration of angiotensin-( 1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats. Neuropeptides 2008; 42: 593-600.
47. Walther T, Balschun D, Voigt JP, Fink H, Zuschratter W, Birchmeier C, Ganten D, Bader M: Sustained long-term potentiation and anxiety in mice lacking the Mas protooncogene. J Biol Chem 1998; 273: 11867-11873. (Pubitemid 28272093)
48. Walther T, Voigt JP, Fink H, Bader M: Sex specific behavioural alterations in Mas-deficient mice. Behav Brain Res 2000; 107: 105-109.
49. Joniec I, Ciesielska A, Kurkowska-Jastrzebska I, Przybylkowski A, Czlonkowska A, Czlonkowski A: Age and sex differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res 2009; 1261: 7-19.
50. Isingrini E, Desmidt T, Belzung C, Camus V: Endothelial dysfunction: a potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease? Curr Opin Investig Drugs 2009; 10: 46-55.